Want to Invest in the FUTURE of AI Medicine? Watch This Now
AI drug stocks are languishing while everything else "AI-related" is going "to the moon." We've been covering AI drug discovery stocks for years now, so they're nothing new. But in this video, we'll check in with two stocks we happen to like, a few we're avoiding, one that was suggested by our Nanalyze Premium subscribers, and one we're holding. As always, revenue growth is the ground truth, so we really need to see more later-stage progress from these contenders before we decide to invest.
Stay informed with our free disruptive technology investing newsletter, Nanalyze Weekly. Sign up now at…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.